M&A / Deals Aditxt and Ignite announce merger plans with strategic partner Pharmaceutical TechnologyAditxt and subsidiary Ignite Proteomics have announced plans for a business combination with a strategic partner.Read full story pharminent June 10, 2026 (Last updated: June 10, 2026) Pharmaceutical Technology Aditxt and subsidiary Ignite Proteomics have announced plans for a business combination with a strategic partner. Read full story Post navigation Previous: Cancer biotech Parabilis books record IPO, raising $670mNext: AbbVie’s migraine drug cleared for migraine attacks on NHS Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
